NMBA anaphylaxis is a rare disease, and we chose to favor a homogenous population with fully characterized IgE-dependant anaphylaxis (i.e. with elevated circulating tryptase and histamine during anaphylaxis and positive skin test to the NMBA received) thus limiting the number of eligible patient in our cohort. Here, IGHE is linked to anaphylaxis.